Su T, Guan Q, Cheng H, Zhu Z, Jiang C, Guo P, et al. Functions of G protein-coupled receptor 56 in health and disease. Acta Physiol (Oxf). 2022;236:e13866.
Article CAS PubMed Google Scholar
Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26:S35–61.
Adlan AM, Lip GY, Paton JF, Kitas GD, Fisher JP. Autonomic function and rheumatoid arthritis: a systematic review. Semin Arthritis Rheum. 2014;44:283–304.
Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE, et al. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum. 2004;33:231–8.
Scanlon EM, Mankad R, Crowson CS, Kullo IJ, Mulvagh SL, Matteson EL, et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing. Clin Rheumatol. 2017;36:763–71.
Dessein PH, Gonzalez-Gay MA. Management of cardiovascular disease risk in rheumatoid arthritis. J Clin Med. 2022;11:3487.
Article PubMed PubMed Central Google Scholar
Lai J, Han Y, Huang C, Li B, Ni J, Dong M, et al. Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements. Lipids Health Dis. 2021;20:137.
Article CAS PubMed PubMed Central Google Scholar
Rezus E, Macovei LA, Burlui AM, Cardoneanu A, Rezus C. Ischemic heart disease and rheumatoid arthritis-two conditions, the same background. Life (Basel). 2021;11:1042.
Leach S, Suzuki K. Adrenergic signaling in circadian control of immunity. Front Immunol. 2020;11:1235.
Article CAS PubMed PubMed Central Google Scholar
Lin TT, Sung YL, Syu JY, Lin KY, Hsu HJ, Liao MT, et al. Anti-inflammatory and antiarrhythmic effects of beta blocker in a rat model of rheumatoid arthritis. J Am Heart Assoc. 2020;9:e016084.
Article CAS PubMed PubMed Central Google Scholar
Wu L, Tai Y, Hu S, Zhang M, Wang R, Zhou W, et al. Bidirectional role of beta2-adrenergic receptor in autoimmune diseases. Front Pharmacol. 2018;9:1313.
Article CAS PubMed PubMed Central Google Scholar
Klatt S, Stangl H, Kunath J, Lowin T, Pongratz G, Straub RH. Peripheral elimination of the sympathetic nervous system stimulates immunocyte retention in lymph nodes and ameliorates collagen type II arthritis. Brain Behav Immun. 2016;54:201–10.
Article CAS PubMed Google Scholar
Wang H, Chai K, Du M, Wang S, Cai JP, Li Y, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circ Heart Fail. 2021;14:e008406.
Wang Q, Wang Y, West TM, Liu Y, Reddy GR, Barbagallo F, et al. Carvedilol induces biased beta1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility. Cardiovasc Res. 2021;117:2237–51.
Article CAS PubMed Google Scholar
Sun H, Wang M, Su T, Guo P, Tai Y, Cheng H, et al. Ziyuglycoside I attenuates collagen-induced arthritis through inhibiting plasma cell expansion. J Ethnopharmacol. 2022;294:115348.
Article CAS PubMed Google Scholar
Zhou WJ, Wang DD, Tao J, Tai Y, Zhou ZW, Wang Z, et al. Deficiency of beta-arrestin2 exacerbates inflammatory arthritis by facilitating plasma cell formation. Acta Pharmacol Sin. 2021;42:755–66.
Article CAS PubMed Google Scholar
Wang Q, Wang L, Wu L, Zhang M, Hu S, Wang R, et al. Paroxetine alleviates T lymphocyte activation and infiltration to joints of collagen-induced arthritis. Sci Rep. 2017;7:45364.
Article CAS PubMed PubMed Central Google Scholar
Wang QT, Zhang LL, Wu HX, Wei W. The expression change of beta-arrestins in fibroblast-like synoviocytes from rats with collagen-induced arthritis and the effect of total glucosides of paeony. J Ethnopharmacol. 2011;133:511–6.
Article CAS PubMed Google Scholar
Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis. 2003;62:414–8.
Article CAS PubMed PubMed Central Google Scholar
Xu B, Li M, Wang Y, Zhao M, Morotti S, Shi Q, et al. GRK5 controls SAP97-dependent cardiotoxic beta1 adrenergic receptor-CaMKII signaling in heart failure. Circ Res. 2020;127:796–810.
Article CAS PubMed PubMed Central Google Scholar
Ferrero KM, Koch WJ. GRK2 in cardiovascular disease and its potential as a therapeutic target. J Mol Cell Cardiol. 2022;172:14–23.
Article CAS PubMed Google Scholar
Lee J, Olivieri C, Ong C, Masterson LR, Gomes S, Lee BS, et al. Raf kinase inhibitory protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop. Proc Natl Acad Sci USA. 2022;119:e2121867119.
Article CAS PubMed PubMed Central Google Scholar
Li D, Guo YY, Cen XF, Qiu HL, Chen S, Zeng XF, et al. Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-kappaB pathways. Acta Pharmacol Sin. 2022;43:1989–2002.
Article CAS PubMed Google Scholar
Wang Q, Liu Y, Fu Q, Xu B, Zhang Y, Kim S, et al. Inhibiting insulin-mediated beta2-adrenergic receptor activation prevents diabetes-associated cardiac dysfunction. Circulation. 2017;135:73–88.
Article CAS PubMed Google Scholar
Park E, Griffin J, Bathon JM. Myocardial dysfunction and heart failure in rheumatoid arthritis. Arthritis Rheumatol. 2022;74:184–99.
Park E, Ito K, Iqbal R, Amigues I, Bokhari S, Van Eyk J, et al. Prospective changes in diastolic function in patients with rheumatoid arthritis. Arthritis Res Ther. 2022;24:184.
Article CAS PubMed PubMed Central Google Scholar
Semb AG, Ikdahl E, Wibetoe G, Crowson C, Rollefstad S. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nat Rev Rheumatol. 2020;16:361–79.
Nikiphorou E, de Lusignan S, Mallen CD, Khavandi K, Bedarida G, Buckley CD, et al. Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study. Heart. 2020;106:1566–72.
Article CAS PubMed Google Scholar
Ritskes-Hoitinga J, Beynen AC. Atherosclerosis in the rat. Artery. 1988;16:25–50.
Heriansyah T, Dimiati H, Hadi TF, Umara DA, Riandi LV, Fajri F, et al. Ascorbic acid vs calcitriol in influencing monocyte chemoattractant protein-1, nitric oxide, superoxide dismutase, as markers of endothelial dysfunction: in vivo study in atherosclerosis rat model. Vasc Health Risk Manag. 2023;19:139–44.
Article CAS PubMed PubMed Central Google Scholar
Zhou Q, Han X, Li R, Zhao W, Bai B, Yan C, et al. Anti-atherosclerosis of oligomeric proanthocyanidins from Rhodiola rosea on rat model via hypolipemic, antioxidant, anti-inflammatory activities together with regulation of endothelial function. Phytomedicine. 2018;51:171–80.
Article CAS PubMed Google Scholar
Bes C, Gurel S, Bugdayci G, Dikbas O, Soy M. Atherosclerosis assessment and rheumatoid arthritis. Z Rheumatol. 2018;77:330–4.
Article CAS PubMed Google Scholar
Reiss AB, Silverman A, Khalfan M, Vernice NA, Kasselman LJ, Carsons SE, et al. Accelerated atherosclerosis in rheumatoid arthritis: mechanisms and treatment. Curr Pharm Des. 2019;25:969–86.
Article CAS PubMed Google Scholar
Da Silva JA, Jacobs JW, Kirwan JR, Boers M, Saag KG, Ines LB, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006;65:285–93.
Baniaamam M, Paulus WJ, Blanken AB, Nurmohamed MT. The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis: a systematic review. Expert Opin Biol Ther. 2018;18:585–94.
Article CAS PubMed Google Scholar
Danila MI, Patkar NM, Curtis JR, Saag KG, Teng GG. Biologics and heart failure in rheumatoid arthritis: are we any wiser? Curr Opin Rheumatol. 2008;20:327–33.
留言 (0)